Prognostic role of brain natriuretic peptide in children of the first year of life with congenital heart defects: a prospective cohort study

Background. Congenital heart defects (CHD) are the most common type of developmental anomalies in children. At present the early diagnosis of congestive heart failure (CHF) and CHF-associated pathologic conditions is becoming increasingly important for optimization of protocols for following up pediatric patients in the primary health care settings.

Objective. The study aimed at determining the prognostic role of brain natriuretic peptide (BNP) as a diagnostic marker of CHF progression and development of CHF-associated pathological conditions in babies with CHD during the first year of life.

Methods. A prospective cohort study was carried out in a total of 114 children of the first year of life. The main study group was comprised of 61 children with confirmed diagnosis of CHD, and the control group of 53 health status group I–IIA children without CHD.

Results. Diagnostic role of BNP elevation > 30 pg/mL was determined. At this BNP level the risk for developing stage 2A CHF increased 7-fold (OR 7.5 [1.8–31.5]), for developing functional class (FC) 2 CHF — nearly 5-fold (OR 4.6 [1.3–16.0]), and for FC 3 CHF such risk increased 9-fold (OR 9.2 [2.3–36.1]). Our results demonstrated that the BNP level measurements can be used in clinical practice to determine the likelihood of persistence of symptoms of perinatal CNS injuries during the first year of life (OR 7.6 [1.7–34.5]) and protein and energy deficit (PED) (OR 9.5 [2.5–35.5]) in children with CHD.

1. Benjamin E.J., Blaha M. J., Chiuve S. E., et al. Heart Disease and Stroke Statistics‑2017 Update: A Report From the American Heart Association. Circulation. 2017;135: е423–е434. doi: 10.1161/CIR.0000000000000485.

2. Krasuski R.A., Bashore T. M. Congenital heart disease epidemiology in the United States: blindly feeling for the charging elephant. Circulation. 2016;134(2):110–113. doi: 10.1161/CIRCULATIONAHA.116.023370.

3. Baranov, A.A., Namazova- Baranova L.S., Basargina E. N., et al. Chronic heart failure in children [Electronic resource]. Moscow; 2016. Access by: http://www. pediatr-russia.ru/sites/default/files/file/kr_hsn.pdf. (In Russ).

4. Baranov A. A., Namazova-Baranova L.S., Bokeriya E. L., Basargina E. N.. Federal Clinical Guidelines for Providing Medical Assistance to Children with Congenital Heart Defects [Electronic resource]. Moscow; 2015. Access by: http://www.pediatr-russia.ru/sites/default/files/file/kr_vps.pdf. (In Russ).

5. Zhelev V. A., Pogudina A. S., Filippov G. P., et al. Clinical and metabolic adaptation of newborns with hypoxic damage to the central nervous system in combination with congenital heart defects. Mother and child in Kuzbass. 2015; 61 (2): 74–78. (In Russ).

6. Fernandes B.A., Maher K. O., Deshpande S. R. Cardiac biomarkers in pediatric heart disease: A state of art review. World J. Cardiol. 2016;8(12):719–727. doi: 10.4330/wjc.v8.i12. 719.

7. Ross R. The Ross Classification for Heart Failure in Children After 25 Years: A Review and an Age-Stratified Revision. Pediatr. Cardiol. 2012;33 (8):1295–1300. doi: 10.1007/s00246-012-0306-8.

8. Srisawasdi P., Vanavanan S., Charoenpanichkit C., Kroll M. H. The effect of renal dysfunction on BNP, NT-proBNP, andtheir ratio. Am J. Clin. Pathol. 2010;133:14–23. doi: 10.1309/AJCP60HTPGIGFCNK.

9. Herskind A.M., Pedersen D. A., Christensen K. Increased prevalence of congenital heart defects in monozygotic and dizygotic twins. Circulation. 2013;128(11):1182–1188. doi: 10.1161/CIRCULATIONAHA.113.002453.

10. Khairy P., Poirier N., Mercier L. A. Univentricular heart. Circulation. 2007;115(6):800–812.

11. Wall K., Oddsson H., Ternestedt B. M., et al. Thirty-year electrocardiographic follow-up after repair of tetralogy of Fallot or atrial septal defect. J Electrocardiol. 2007;40:214–217.

12. Ruiz A., Cruz-Lemini M., Masoller N., et al. Longitudinal changes in fetal biometry and cerebroplacental hemodynamics in fetuses with congenital heart disease. Ultrasound Obstet Gynecol. 2017;49:379–386. doi: 10.1002/uog.15970.

13. Gaynor J.W., Stopp C., Wypij D., et al. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 2017; 135:816–825. doi: 10.1542/peds.2014–3825.

14. Bean Jaworski J. L., Flynn T., Burnham N., et al. Rates of autism and potential risk factors in children with congenital heart defects. Congenit Heart Dis. 2017;12(4):421–429. doi: 10.1111/chd.12461.

15. Mussatto K.A., Hoffmann R., Hoffman G., et al. Risk factors for abnormal developmental trajectories in young children with congenital heartdisease. Circulation. 2015;132:755–762.

16. Gandaeva L. A., Borovik T. E., Basargina E. N., Zvonkova N. G., Skvortsova V. A., Semenova N. N. The relevance of assessing nutritional status in children with chronic heart failure. Voprosy sovremennoy pediatrii — Current pediatrics. 2015;14(6):699–705. (In Russ).